During the past decade, Affiliated hospital of chengde medical university conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Affiliated hospital of chengde medical university" #1 sponsor was "Beijing Tiantan Hospital" with 1 trials, followed by "Betta Pharmaceuticals Co., Ltd." with 1 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored, "China Academy of Chinese Medical Sciences" with 1 trials sponsored and "Harbin Medical University" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Affiliated hospital of chengde medical university" #1 collaborator was "China Food and Drug Administration" with 1 trials as a collaborator, "Chinese Society of Cardiology" with 1 trials as a collaborator, "Guangzhou Recomgen Biotech Co., Ltd." with 1 trials as a collaborator and "Lepu Medical Technology (Beijing) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Affiliated hospital of chengde medical university" are "Acute Coronary Syndrome" (1 trials), "Acute Ischemic Stroke" (1 trials), "Acute Stroke" (1 trials), "Advanced Biliary Cancer" (1 trials) and "Arterial Occlusive Diseases" (1 trials). Many other conditions were trialed in "Affiliated hospital of chengde medical university" in a lesser frequency.

Most popular intervention types in "Affiliated hospital of chengde medical university" are "Drug" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (2 trials), "Anlotinib hydrochloride" (1 trials), "Aspirin monotherapy" (1 trials), "BPI-16350" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Affiliated hospital of chengde medical university" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Affiliated hospital of chengde medical university". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Affiliated hospital of chengde medical university, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Affiliated hospital of chengde medical university, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".